Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01129492
Other study ID # CAPPesq 375/05
Secondary ID
Status Completed
Phase Phase 2
First received May 14, 2010
Last updated May 21, 2010
Start date March 2006
Est. completion date March 2009

Study information

Verified date April 2009
Source University of Sao Paulo General Hospital
Contact n/a
Is FDA regulated No
Health authority Brazil: National Committee of Ethics in Research
Study type Interventional

Clinical Trial Summary

The purpose of this study is to evaluate whether low-level Laser therapy is effective in ameliorating the thyroid function of patients with hypothyroidism caused by chronic autoimmune thyroiditis.


Description:

Chronic autoimmune thyroiditis (CAT) is the most common cause of hypothyroidism in iodine-replete areas. An autoimmune dysfunction causes humoral and cellular responses that lead progressively to thyroiditis. There is no effective therapy available that can change the natural history of CAT, which presents a high incidence of hypothyroidism and requires continuous treatment with levothyroxine (LT4).

Laser light can be valuable since the local and systemic actions of low-level laser therapy (LLLT) have been shown to be effective in treating autoimmune diseases, such as rheumatoid arthritis and Sjogren's syndrome. There is also evidence suggesting that LLLT can facilitate regeneration of various tissues and, in animal thyroids, can lead to improvement in microcirculation and increases in serum triiodothyronine (T3) and thyroxine (T4) levels. Since the LLLT is a non-invasive, cost-effective and painless procedure, the objective of this randomized clinical trial was to evaluate the effectiveness of LLLT in patients with hypothyroidism caused by chronic autoimmune thyroiditis, based on patients' thyroid function, their concentration of thyroid autoantibodies, and the parameters of their ultrasonography study.


Recruitment information / eligibility

Status Completed
Enrollment 43
Est. completion date March 2009
Est. primary completion date March 2009
Accepts healthy volunteers No
Gender Both
Age group 20 Years to 60 Years
Eligibility Inclusion Criteria:

- Patients previously diagnosed with hypothyroidism induced by chronic autoimmune thyroiditis (CAT). The presence of hypothyroidism, laboratory measurements and ultrasonography criteria were applied to diagnose CAT.

- Significantly elevated concentrations of thyroid peroxidase (TPOAb) and/or thyroglobulin (TgAb) autoantibodies

- Ultrasonography results consistent with CAT

- Patients undergoing LT4 treatment

- Normal (or almost normal) levels of triiodothyronine (T3), thyroxine (T4), free T4 and thyrotropin (TSH)

Exclusion Criteria:

- Use of immunosuppressants, immunostimulants, or other drugs that could interfere with the production, metabolism and transport of thyroid hormones

- CAT with normal thyroid function

- CAT with subclinical hypothyroidism

- Thyroid nodules

- Hypothyroidism stemming from post-partum thyroiditis (up to 18 months after gestation)

- History of Graves' disease

- Thyrotropin receptor antibody (TRAb) detectable

- Prior treatment with radioiodine

- Tracheal stenosis

- Pregnancy

- History of ionizing irradiation and/or neoplasia in the cervical area

- Previous surgical intervention in the thyroid

- Thyroid hypoplasia

- Ectopic thyroid

- Serious illness (cancer, ischemic coronary artery disease, stroke, kidney or liver failure, etc.)

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Outcomes Assessor), Primary Purpose: Treatment


Intervention

Device:
Low-level Laser therapy
A continuous wave (CW) diode laser device (830nm, infrared) with a beam area of 0.2827cm2 and using the punctual method, continuous emission mode, output power of de 50mW and fluence of 70J/cm2 (40 seconds at the point of application).

Locations

Country Name City State
Brazil University of Sao Paulo General Hospital São Paulo

Sponsors (4)

Lead Sponsor Collaborator
University of Sao Paulo General Hospital Conselho Nacional de Desenvolvimento Científico e Tecnológico, Coordenação de Aperfeiçoamento de Pessoal de Nível Superior., Fundação de Amparo à Pesquisa do Estado de São Paulo

Country where clinical trial is conducted

Brazil, 

Outcome

Type Measure Description Time frame Safety issue
Primary The main outcome measure was to gauge the effectiveness of applying LLLT in patients with hypothyroidism caused by CAT evaluated by a significant reduction of the levothyroxine (LT4) mean dose (µ/day) 9 months post-LT4 withdrawal. All patients enrolled in the study were undergoing LT4 treatment. They received 10 applications of LLLT or placebo. Thirty days after intervention, LT4 was discontinued in all patients and, if required, reintroduced. T3, T4, free T4 and TSH levels (all laboratory personnel was blinded), were assessed pre-LLLT and then 1, 2, 3, 6 and 9 months post-LT4 withdrawal. The LT4 mean dose pre-LLLT and 9 months post-LT4 withdrawal was compared both in face of normal levels of T3, T4, free T4 and TSH to evaluate LLLT effectiveness. LT4 dose, concentrations of T3, T4, free T4 and TSH were evaluated and compared before intervention and 9 months post-LT4 withdrawal. Yes
Secondary Evaluate the LLLT efficacy in reducing thyroid autoantibodies concentrations. Thyroid peroxidase (TPOAb) and thyroglobulin (TgAb) autoantibodies were both determined prior to LLLT and in the 1st, 2nd, 3rd, 6th and 9th months after LT4 withdrawal. All laboratory personnel was blinded to treatment assignment throughout the study. Thyroid autoantibodies were determined and compared pre-intervention and 9 months post-LT4 withdrawal. Yes
Secondary Evaluate the LLLT efficacy by quantitative and qualitative ultrasonography parameters. B-mode sonography (volume, texture and echogenicity using computerized histogram) as well as power Doppler (vascularization) and pulsed Doppler (maximal systolic peak velocity and resistance index for the thyroid arteries) were performed and compared pre- and 30 days post-intervention by only one experienced and blind investigator, during the use of the same doses of LT4. The ultrasonography parameters observed pre-LLLT were compared with those observed 30 days post-LLLT. Yes
See also
  Status Clinical Trial Phase
Completed NCT06249074 - Gluten-free Diet in Women With Autoimmune Thyroiditis N/A
Completed NCT02240563 - Low Level Laser Therapy for Autoimmune Thyroiditis N/A
Not yet recruiting NCT05544448 - In Vitro Effect Study of Interleukin-2 Muteins on Regulatory T Cells of Patients With Different Autoimmune, Allo-immune or Inflammatory Diseases N/A
Completed NCT03289403 - The Role of Immunomodulatory Treatment in Success of ICSI in Patients With Autoimmune Thyroiditis Phase 2
Completed NCT02013479 - Selenium Supplementation in Autoimmune Thyroiditis N/A
Completed NCT03048708 - Thyroid in Bariatric Surgery N/A
Completed NCT03498417 - Anti-insulin-like Growth Factor-1 Receptor (IGF-1R) Antibodies in Graves' Disease and Graves' Orbitopathy
Completed NCT02318160 - Oxidative Status in Children With Autoimmune Thyroiditis N/A
Completed NCT05680376 - Thyroid Hormone Values and Anti-thyroid Peroxidase Antibody Positivity in Recurrent Pregnancy Loss
Completed NCT04754607 - Effects of Low-Level Laser Therapy on Oxidative Stress Levels... N/A
Completed NCT04600349 - Identity Oriented Psychotrauma Therapy on Hashimoto in Adults N/A
Completed NCT00271427 - Selenium Treatment in Autoimmune Thyroiditis (AIT) N/A
Completed NCT02644707 - Selenium Supplementation in Youths With Autoimmune Thyroiditis Phase 4